The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery

Abstract

In pancreatic adenocarcinoma patients with LN disease, survival after PD is comparable regardless of HALN status. Therefore, HALN-positive disease should not preclude the performance of PD.

Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis

“…Table 1 summarizes the characteristics of included studies. [18][19][20][21][22][23][24][25][26][27][28][29] One study was excluded due to overlap in its patient population with another study assessing additionally extraregional LNM. 29,30 No studies were excluded due to inadequate methodological quality ( Supplementary Table).…”

Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: A systematic review and meta-analysis

“…Table 1 summarizes the characteristics of included studies. [18][19][20][21][22][23][24][25][26][27][28][29] One study was excluded due to overlap in its patient population with another study assessing additionally extraregional LNM. 29,30 No studies were excluded due to inadequate methodological quality (Supplementary Table).…”

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

“…Because the number of negative lymph nodes and the total lymph node count influence stage‐based survival prediction, the College of American Pathologists recommends microscopic evaluation of at least 12 lymph nodes for pancreatectomy specimens 185,196,197 . Some groups advocate for reporting the involvement of specific lymph node groups, such as the hepatic artery lymph nodes; however, the prognostic value of this practice remains controversial in light of contradictory data from retrospective studies 198‐200 …”